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Abstract The mitochondrial carrier protein for carnitine has
been identified in Saccharomyces cerevisiae. It is encoded by the
gene CRC1 and is a member of the family of mitochondrial
transport proteins. The protein has been over-expressed with a C-
terminal His-tag in S. cerevisiae and isolated from mitochondria
by nickel affinity chromatography. The purified protein has been
reconstituted into proteoliposomes and its transport character-
istics established. It transports carnitine, acetylcarnitine, pro-
pionylcarnitine and to a much lower extent medium- and long-
chain acylcarnitines.
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1. Introduction
Mitochondria are impermeable to acyl-CoAs of any chain
length. To traverse the inner mitochondrial membrane, acyl
residues are transiently transferred to L-carnitine by speci¢c
carnitine acyltransferases. The carnitine/acylcarnitine translo-
case (CACT) from mammalian mitochondria catalyses the
entry of acylcarnitines of various lengths in exchange for
free carnitine into the mitochondrial matrix where the acyl
moieties are oxidised by the enzymes of the L-oxidation path-
way and the tricarboxylic acid cycle [1,2]. Because of its fun-
damental role in bioenergetics, the basic functional properties
of CACT have been extensively investigated in intact mito-
chondria and with puri¢ed protein incorporated into lipo-
somes [3]. Recently, CACT has been cloned from man and
rat [3,4] and its primary structure shows that it is a member of
the mitochondrial carrier family [5^7]. Human CACT de¢-
ciency impairs fatty acid oxidation [4] and CACT was the ¢rst
gene for a mitochondrial carrier associated with a human
disease [4].
Fungal genes encoding CACT have not been identi¢ed hith-
erto nor has its product been isolated and characterised. How-
ever, several facts point to its existence in Saccharomyces ce-
revisiae. For example acetylcarnitine is known to be involved
in shuttling acetyl groups across the inner mitochondrial
membrane [8], and two carnitine acetyltransferases are known
[9]. One, YAT1, is located at the outer membrane of mito-
chondria and is ethanol-inducible. The other, encoded by the
CAT2 gene and found in both mitochondria and peroxisomes,
accounts for s 95% of the total carnitine acetyltransferase
activity in yeast [10]. S. cerevisiae encodes 35 members of
the mitochondrial transporter family [11]. The transport func-
tions of most family members are unknown. Among them, the
CRC11 gene product is the most closely related to CACT
(29% identity). This gene is the only one in S. cerevisiae en-
coding a member of the mitochondrial carrier family that has
a promoter region containing an ORE (oleate-responsive ele-
ment) and its transcription has been shown to be induced by
oleate [12].
In the present work, the CRC protein has been over-ex-
pressed in S. cerevisiae with a C-terminal histidine tail and
puri¢ed by a⁄nity chromatography. Upon functional recon-
stitution into liposomes, it has been shown to be a carnitine
carrier that also transports acetylcarnitine, propionylcarnitine
and, much less e⁄ciently, medium- and long-chain acylcarni-
tines. This report is the ¢rst information about the molecular
properties of the yeast carnitine carrier, and it provides the
de¢nitive identi¢cation of its gene.
2. Materials and methods
2.1. Construction of the CRC expression plasmid
The coding sequence for CRC (YOR100c; GenBank accession
number AJ250124) was ampli¢ed from S. cerevisiae genomic DNA
via PCR. Forward and reverse oligonucleotide primers were synthe-
sised corresponding to the extremities of the CRC1 sequence with
additional HindIII and BamHI sites, respectively. The reverse primer
also contained 18 extra bases encoding a 6-histidine tag immediately
before the stop codon. The PCR product was cloned into the expres-
sion vector pYES2 (Invitrogen). The resulting expression plasmid was
introduced in the S. cerevisiae YPH499 strain [13] (wild-type), and
transformants (CRC1-pYES2 cells) were selected for uracil auxotro-
phy. Other conditions have been given before [14^16].
2.2. High-level expression and puri¢cation of the CRC protein
Yeasts were precultured in synthetic medium as previously de-
scribed [16]. For the preparation of mitochondria yeast cells were
grown at 30‡C to mid-log phase in YP medium (1% yeast extract,
2% Bacto-peptone, pH adjusted to 4.8 with HCl) supplemented with
3% glycerol and 0.1% glucose. Galactose (0.5%) was added 6 h before
harvesting (5 min at 3000Ug). Mitochondria were isolated according
to standard procedures [17] and solubilised in bu¡er A (500 mM
NaCl, 10 mM PIPES, pH 7.0) containing 2% Triton X-100 (w/v)
and 4 mg/ml cardiolipin, at a ¢nal concentration of 0.4 mg protein/
ml. After incubation for 20 min at 4‡C, the mixture was spun at
138 000Ug for 20 min. The supernatant extract (1.1 ml) was incubated
batchwise for 40 min with 0.35 ml Ni-NTA agarose (Qiagen) previ-
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ously equilibrated with bu¡er A. Then the resin was packed into a
column (0.5 cm internal diameter) and washed with 10 ml of bu¡er B
(100 mM NaCl, 0.4% Triton X-100, 10 mM PIPES, pH 7.0) in the
presence of 10 mM imidazole. Elution was carried out using an imid-
azole gradient (10^100 mM imidazole in bu¡er B). Pure CRC pro-
tein eluted at an imidazole concentration of 80 mM. Protein was
determined by the Lowry method modi¢ed for the presence of deter-
gent [18] or by laser densitometry [11,15].
2.3. Protein chemical characterisation of over-expressed CRC
The analysis of proteins by SDS-PAGE and N-terminal sequencing
has been described previously [14]. For internal sequence determina-
tions, the puri¢ed CRC protein was digested with cyanogen bromide
as described [3]; the peptides were separated by SDS-PAGE as de-
scribed by Scha«gger and von Jagow [19], transferred to poly(vinyli-
dene di£uoride) membranes, stained with Coomassie blue dye, and
their N-terminal sequences determined with a pulsed liquid protein
sequencer (Applied Biosystems 477A).
2.4. Activity assays
CRC was reconstituted into proteoliposomes as described for other
mitochondrial carriers [15,20]. External substrate was removed from
proteoliposomes on a Sephadex G-75 column preequilibrated with
bu¡er C (50 mM NaCl, 10 mM PIPES, pH 7.0). Transport at 25‡C
was started by adding [3H]carnitine (from Amersham Pharmacia Bio-
tech) to the proteoliposomes and terminated by addition of 40 mM
pyridoxal 5P-phosphate and 15 mM bathophenanthroline (the ‘inhib-
itor-stop’ method [20]). In control samples, the inhibitors were added
with the labelled substrate. The transport activities were calculated
from the experimental values minus the controls. For kinetic measure-
ments, transport was stopped after 1 min, i.e. within the initial linear
range of [3H]carnitine uptake into the proteoliposomes. Various other
transport activities were also assayed by the inhibitor-stop method.
For e¥ux measurements, the internal substrate pool of the proteoli-
posomes was made radioactive by carrier-mediated exchange equili-
bration [20] with 3 mM [3H]carnitine added at high speci¢c radio-
activity. After 60 min, the residual external radioactivity was
removed by passing the proteoliposomes again through a column of
Sephadex G-75. E¥ux was started by adding unlabelled external sub-
strate or bu¡er C alone and terminated by adding the inhibitors in-
dicated above.
3. Results and discussion
3.1. Over-expression of CRC
CRC was expressed at high level in yeast mitochondria
from the multicopy vector pYES2 (Fig. 1, lane 2). The protein
has an apparent molecular mass of about 40 kDa (the calcu-
lated molecular mass including the initiator methionine and
the histidine tag is 35 550 Da). It was estimated to represent
about 12% of the total mitochondrial protein. The presence of
the C-terminal histidine tail allowed the CRC to be puri¢ed
by Ni-agarose chromatography (Fig. 1, lane 3). About 0.2
mg of puri¢ed protein was obtained per litre of yeast culture.
The puri¢ed protein does not have a free K-amino group, and
so its identity was con¢rmed by sequencing two internal cya-
nogen bromide fragments. Three fragments were detected on
SDS-PAGE gels. Like the intact protein the upper band (ap-
proximately 16 kDa) gave no N-terminal sequence, whereas
the two lower bands (12 kDa and 5 kDa) gave sequences
identical to residues 145^154 and 277^286 of the CRC
(AAAGFISAIP and LSATKEIYLQ, respectively).
Table 1
Carnitine transport by yeast CRC and the e¡ects of inhibitors
Protein Inhibitor [3H]Carnitine uptake (Wmol/15 min/g protein)
YPH499 extract none 39
CRC1-pYES2 extract none 825
Pure CRC none 7940
Pure CRC mersalyl 238
Pure CRC p-chloromercuribenzensulphonate 476
Pure CRC mercuric chloride 318
Pure CRC N-ethylmaleimide 2461
Pure CRC pyridoxal 5P-phosphate 1746
Pure CRC bathophenanthroline 2461
Pure CRC K-cyanocinnamate 7146
Pure CRC carboxyatractyloside 7543
Pure CRC phenylsuccinate 8845
Pure CRC butylmalonate 8099
Pure CRC 1,2,3-benzenetricarboxylate 8560
The [3H]carnitine/carnitine exchange was measured in liposomes reconstituted with mitochondrial yeast extracts of wild-type or CRC1-pYES2
cells, and with the CRC protein puri¢ed from the latter strain. The proteoliposomes were preloaded with 13 mM carnitine and transport was
started by adding 0.1 mM [3H]carnitine. Thiol reagents, pyridoxal 5P-phosphate, carboxyatractyloside and K-cyanocinnamate were added 3 min
before the labelled substrate; other inhibitors were added together with [3H]carnitine. The ¢nal concentration of all inhibitors was 15 mM, ex-
cept for organic mercurials and carboxyatractyloside (0.1 mM), K-cyanocinnamate and N-ethylmaleimide (2 mM). Similar results were obtained
in 2^4 independent experiments.
Fig. 1. Puri¢cation of the over-expressed yeast carnitine carrier. Pro-
teins were separated by SDS-PAGE and stained with silver nitrate.
The positions of molecular weight markers are shown on the left in
kDa. Lanes 1 and 2, mitochondrial protein (10 Wg) from wild-type
(lane 1) and CRC1-pYES2 strain (lane 2). Cells were harvested 6 h
after addition of galactose. Lane 3, CRC protein (1.5 Wg) puri¢ed
from mitochondria in lane 2.
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The yeast CRC catalysed transport of carnitine (see Table
1). The uptake of [3H]carnitine was measured in proteolipo-
somes that had been reconstituted with a Triton X-100 extract
of CRC1-pYES2 mitochondria and that contained 13 mM
carnitine. The uptake was more than 20-fold higher than by
similar proteoliposomes that had been reconstituted with a
mitochondrial extract from wild-type cells. Furthermore, the
puri¢ed recombinant CRC reconstituted into proteoliposomes
had an even greater carnitine carrier activity. The same pro-
teoliposomes did not catalyse homoexchanges of phosphate,
ATP, citrate, malate, oxoglutarate, succinate, fumarate, glu-
tamate, aspartate, glutamine, and ornithine (external concen-
tration, 1 mM; internal concentration, 10 mM) (data not
shown), and no carnitine/carnitine homoexchange was de-
tected with puri¢ed CRC that had been boiled before incor-
poration into liposomes (not shown).
The activity of the puri¢ed CRC protein was markedly in-
hibited by sulphydryl reagents, pyridoxal 5P-phosphate and
bathophenanthroline (Table 1). In contrast, inhibitors of oth-
er mitochondrial carriers such as K-cyanocinnamate, carbox-
yatractyloside, phenylsuccinate, butylmalonate and 1,2,3-ben-
zenetricarboxylate had very little or no e¡ect on the
reconstituted carnitine transport. These results show that the
inhibition characteristics of the recombinant CRC protein are
similar to those previously described for the mammalian car-
nitine carrier [1,21].
3.2. Substrate speci¢city
The substrate speci¢city of the puri¢ed CRC was investi-
gated in greater detail by measuring the uptake of external
[3H]carnitine into proteoliposomes which had been pre-loaded
with di¡erent compounds. As shown in Table 2, [3H]carnitine
was e⁄ciently taken up by proteoliposomes containing
13 mM internal carnitine, acetylcarnitine or propionylcarni-
tine. A much lower activity was observed in the presence of
internal D-stereoisomers. Because of their detergent properties,
the e¡ect of intraliposomal medium and long-chain fatty acid
esters of carnitine was tested at a concentration of 2 and 1
mM, instead of 13 mM. In separate experiments neither
L-nonanoylcarnitine nor L-palmitoylcarnitine up to 2 mM
had any appreciable solubilising e¡ect on reconstituted lipo-
somes [21]. The exchange of [3H]carnitine for internal octa-
noylcarnitine, nonanoylcarnitine, lauroylcarnitine, myristoyl-
carnitine and palmitoylcarnitine was much lower than for
Fig. 2. E¥ux of [3H]carnitine from proteoliposomes. Proteolipo-
somes were reconstituted in the presence of 3 mM carnitine, and
then the internal substrate pool was labelled by carrier-mediated ex-
change equilibration. After removal of external substrate by Sepha-
dex G-75 chromatography, the e¥ux of [3H]carnitine was started by
adding bu¡er C alone (uniport, a) or 0.2 mM L-carnitine (E), 0.2
mM L-acetylcarnitine (b), 0.2 mM L-nonanoylcarnitine (O) or 0.2
mM L-palmitoylcarnitine (R) or 40 mM pyridoxal 5P-phosphate and
15 mM bathophenanthroline (F) in the same bu¡er.
Fig. 3. E¡ect of external carnitine concentration on the rate of car-
nitine/carnitine exchange in reconstituted liposomes and competitive
inhibition by acetylcarnitine and propionylcarnitine. [3H]Carnitine
was added at various concentrations to proteoliposomes containing
20 mM carnitine. Except in controls (a), 2.5 mM L-acetylcarnitine
(E) or 2.5 mM L-propionylcarnitine (b) was added simultaneously
with the labelled substrate.
Table 2
E¡ect of internal substrate on the transport properties of proteoli-
posomes containing recombinant yeast CRC
Internal substrate Concentration
(mM)
Carnitine transport
(Wmol/15 min/g protein)
None ^ 83
L-Carnitine 13 8890
D-Carnitine 13 3349
DL-Carnitine 13 4791
L-Acetylcarnitine 13 6446
DL-Acetylcarnitine 13 5154
L-Propionylcarnitine 13 6090
L-Carnitine 2 3590
L-Acetylcarnitine 2 3458
L-Propionylcarnitine 2 3383
L-Nonanoylcarnitine 2 1312
L-Palmitoylcarnitine 2 391
L-Carnitine 1 2203
L-Acetylcarnitine 1 2853
L-Propionylcarnitine 1 2467
DL-Octanoylcarnitine 1 419
L-Nonanoylcarnitine 1 412
DL-Lauroylcarnitine 1 695
DL-Myristoylcarnitine 1 245
L-Palmitoylcarnitine 1 181
DL-Stearoylcarnitine 1 121
Proteoliposomes were pre-loaded internally with various substrates
at the indicated concentrations. Transport was started by the exter-
nal addition of 0.1 mM [3H]carnitine, and stopped after 15 min.
Similar results were obtained in three independent experiments.
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carnitine, acetylcarnitine and propionylcarnitine (see Table 2).
Therefore medium- and long-chain fatty acid esters of carni-
tine are poor substrates for the S. cerevisiae carnitine carrier.
In this respect, the yeast CRC di¡ers from the rat homologue
[1,21,22]. No exchange was observed with internal 13 mM
arginine, glutamine, glutamate, phosphate, oxoglutarate, suc-
cinate, fumarate, pyruvate, ornithine, betaine, choline, citrate
and ATP (not shown). The residual activity in the presence of
these substrates was virtually the same as the activity observed
in their absence.
The rat carnitine carrier catalyses a low unidirectional
transport (uniport) of carnitine in addition to the carnitine/
acylcarnitine exchange [23]. In order to obtain further infor-
mation about the transport characteristics of CRC, the e¥ux
of [3H]carnitine from pre-labelled active proteoliposomes was
studied as it provides a more convenient assay for unidirec-
tional transport [20]. In Fig. 2 the time course of the uniport
measured as e¥ux of 3 mM [3H]carnitine is compared to the
exchange reaction measured under the same conditions in the
presence of various substrates. In the absence of external sub-
strate, a slow e¥ux of [3H]carnitine was detected; its rate (112
cpm/min) was much lower than that observed in the presence
of 0.2 mM acetylcarnitine (1612 cpm/min). Medium- and
long-chain fatty acids esters of carnitine (i.e. L-nonanoylcarni-
tine and L-palmitoylcarnitine) were also exchanged for
[3H]carnitine, although at a lower rate than external carnitine
and acetylcarnitine.
3.3. Kinetic characteristics of reconstituted CRC
The basic kinetic data of the recombinant puri¢ed CRC
were determined by measuring the initial transport rate at
various external carnitine concentrations, in the presence of
a constant saturating internal concentration of 20 mM carni-
tine. The Km and Vmax values for carnitine exchange at 25‡C,
from a typical experiment (see Fig. 3), were 1.79 mM and 15.1
mmol/min per g protein, respectively, and the average values
from ten experiments were 1.9 þ 0.2 mM and 15.1 þ 3.7 mmol/
min per g protein, respectively. Acetylcarnitine and propionyl-
carnitine, which are also good substrates of CRC, inhibited
carnitine uptake competitively. Their Ki values for
[3H]carnitine uptake were 1.5 þ 0.2 mM and 2.0 þ 0.1 mM,
respectively (average of four experiments). In similar experi-
ments, the inhibition constants of medium- and long-chain
acylcarnitines for the rat CRC homologue were found to be
in the micromolar range [21,22] In contrast, L-nonanoylcarni-
tine and L-palmitoylcarnitine at a concentration of 0.2 mM
(i.e. about 30-fold higher than their Ki for the rat carnitine
carrier) did not signi¢cantly inhibit the rate of [3H]carnitine/
carnitine exchange catalysed by the CRC protein (not shown).
3.4. Conclusions
The transport characteristics of the yeast CRC protein
show that it is a carnitine transporter. It also transports
short-chain acylcarnitines with high e⁄ciency and medium-
and long-chain derivatives to a much lower extent. In contrast
to mammals, where only very long-chain fatty acids are short-
ened in peroxisomes and all the other acyl groups are trans-
ported and oxidised in the mitochondria, in S. cerevisiae fatty
acid L-oxidation is restricted to peroxisomes [24]. In the light
of the transport characteristics of the yeast CRC protein it is
likely that the main physiological function of the yeast carni-
tine carrier is to import acetylcarnitine (generated in the per-
oxisomes by CAT2 protein) into the mitochondrion in ex-
change for free carnitine. This conclusion is consistent with
the co-regulation by oleate of the CRC1 gene and the CAT2
gene encoding the major carnitine acetyltransferase [10,12]. In
mammals the carnitine carrier has probably evolved to bind
and transport medium- and long-chain acylcarnitines with
high e⁄ciency.
In addition to being involved in the complete oxidation of
fatty acids, the CRC protein may also participate in the oxi-
dation of the fermentation product ethanol, which is con-
verted to acetate and then activated to acetyl-CoA in the
cytosol. This suggestion implies transfer of the acetyl moiety
to L-carnitine by the YAT1 protein located in the mitochon-
drial outer compartment. Expression of this carnitine acetyl-
transferase is induced by ethanol and acetate, but not oleate
[9,12]. It is noteworthy that a closely related homologue in
Aspergillus nidulans (named ACUH) is required for the myce-
lium growth on long-chain fatty acids or acetate [25]. In ad-
dition, propionylcarnitine transport into the mitochondrion
by CRC may be needed for propionate metabolism which,
in S. cerevisiae, occurs via the methylcitrate pathway [26]
within the mitochondrion (J.T. Pronk Delft, personal commu-
nication). Like its mammalian homologue, the most likely
sub-cellular localisation of the CRC protein is the mitochon-
drial inner membrane. It has a N-terminal amphipathic
stretch (absent from mammalian counterparts), which has
some of the characteristic features of presequences that direct
proteins to mitochondria [25]. It has been suggested that the
rat carnitine carrier may also be targeted to peroxisomes [27].
Further experimentation is required to examine whether CRC
is also present in the peroxisomal membranes.
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